Herpes Zoster
Herpes zoster vaccine effective, shows ‘no signs’ of increased severe flare risk in lupus
WASHINGTON — Herpes zoster vaccination is effective in patients with systemic lupus erythematosus and multiple sclerosis, without increasing the risk for severe lupus flares, according to data presented at ACR Convergence 2024.
Making sense of zoster vaccination in the immunocompromised: ‘It’s all about treatment’
Protecting immunocompromised individuals from infections like herpes zoster is an ongoing challenge for every rheumatologist.
Man presents with right-sided headaches, ocular pain and vesicular rash
A 64-year-old man presented to the emergency department at Lahey Hospital with a 6-day history of right-sided headaches, right ocular pain and vesicular rash.
Herpes Zoster Prevention in the Immunocompromised — Featuring Curbside Consults
This educational activity is supported by an educational grant from GSK.
Patients with IBD in ‘socially vulnerable’ communities less likely to be vaccinated
DENVER — Socioeconomic status, household composition and housing or transportation were among predictors of low vaccination rates in patients with inflammatory bowel disease, according to a presenter at the Crohn’s and Colitis Congress.
Shingles associated with long-term risk for major CV events
Compared with those without it, adults with herpes zoster, also known as shingles, had higher long-term risk for a major CV event, researchers reported.
Litifilimab superior to placebo in reducing tender, swollen joints in lupus
Litifilimab is superior to placebo in reducing tender and swollen joints among patients with systemic lupus erythematosus, according to phase 2 trial data published in the New England Journal of Medicine.
Herpes zoster incidence higher among patients with IBD vs. general population
SAN DIEGO — Patients with inflammatory bowel disease had a higher incidence of herpes zoster than the general population, demonstrating a need for preventive measures, according to research presented at Digestive Disease Week 2022.
Older adults with COVID-19 have significantly increased risk for herpes zoster
People aged 50 years or older with COVID-19 had a 15% increased risk for developing herpes zoster, according to the results of a large retrospective cohort study.
Less than 10% of Medicaid patients with lupus vaccinated against preventable disease
Less than 10% of Medicaid beneficiaries with systemic lupus erythematosus are vaccinated against preventable diseases such as influenza, herpes zoster, cervical cancer and others, according to data published in Arthritis Care & Research.